[1] WESTPHALEN C B, KREBS M G, LE TOURNEAU C, et al. Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population[J]. NPJ Precis Oncol,2021,5(1):69.
[2] TSAI J W, LEE J C, HSIEH T H, et al. Adult NTRK-rearranged spinde cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements[J]. Mod Pathol,2022,35(7):911-921.
[3] AGARAM N P, ZHANG L, SUNG Y S, et al. Recurrent NTRK1 gene fusions define a novel subset of locally aggressive lipofibromatosis-like neural tumors[J]. Am J Surg Pathol,2016,40(10):1407-1416.
[4] SHAW A T, HSU P P, AWAD M M, et al. Tyrosine kinase gene rearragements in epithelial malignancies[J]. Nat Rev Cancer,2013,13(11):772-787.
[5] SO Y K, CHOW C, TO K F, et al. Myxoidspindle cell sarcoma with LMNA-NTRK fusion: expanding the morphologic spectrum of NTRK-rearranged tumors[J]. Int J Surg Pathol,2020,28(5):574-578.
[6] 殷敏智,马靖,何巧,等. 儿童NTRK重排间叶源性肿瘤临床病理学观察[J]. 中华病理学杂志,2020,49(7):675-680.
[7] ATIQ M A, DAVIS J L, HORNICK J L, et al. Mesenchymal tumors of the gastrointestinal tract with NTRK rearrangements: a clinicopathological, immunophenotypic, and molecular study of eight cases, emphasizing their distinction from gastrointestinal stromal tumor (GIST)[J]. Mod Pathol,2021,34(1):95-103.
[8] 沈秋龙,陈亚军,彭春辉,等.单中心儿童继发性肠套叠的临床特点总结[J].中华小儿外科杂志, 2017,38(12):907-910.
[9] DEMETRI G D, ANTONESCU C R, BJERKEHAGEN B, et al. Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network[J]. Ann Oncol,2020,31(11):1506-1517.
[10] SOLOMON J P, HECHTMAN J F. Detection of NTRK fusions: merits and limitations of current diagnostic platforms[J]. Cancer Res,2019,79(13):3163-3168.
[11] RUDZINSKI E R, LOCKWOOD C M, STOHR B A, et al. Pan-Trk immunohistochemistry identifies NTRK rearrangements in pediatric mesenchymal tumors[J]. Am J Surg Pathol,2018,42(7):927-935.
[12] SURREY L F, DAVIS J L. NTRK-Rearranged soft tissue neoplasms: a review of evolving diagnostic entities and algorithmic detection methods[J]. Cancer Genet,2022,260-261:6-13.
[13] REKHI B, SHETTY O, BAPAT P, et al.A Case of Inv(1)(q23q31) TPR-NTRK1 fusion-positive spindle cell neoplasm in an infant—uncovered by next-generation sequencing: diagnostic challenge, review, and therapeutic implications[J]. Int J Surg Pathol,2021,29(1):102-108.
[14] 中国抗癌协会小儿肿瘤专业委员会,中国研究型医院学会儿童肿瘤专业委员会,王焕民,等. 拉罗替尼治疗TRK融合儿童肿瘤中国专家共识[J]. 中国肿瘤临床,2023,50(17):865-872.
[15] LAETSCH T W, VOSS S, LUDWIG K, et al. Larotrectinib for newly diagnosed infantile fibrosarcoma and other pediatric NTRK fusion-positive solid tumors (Children′s Oncology Group ADVL1823)[J]. J Clin Oncol,2025,43(10):1188-1197.
[1]冯伟,苏小霞,邹玉凤,等.超重/肥胖对儿童肠套叠空气灌肠复位的预后影响:倾向性评分匹配分析[J].天津医科大学学报,2021,27(02):137.
FENG Wei,SU Xiao-xia,ZOU Yu-feng,et al.Effect of overweight and obesity on the prognosis of intussusception treated by air enema reduction in children: propensity score matching analysis[J].Journal of Tianjin Medical University,2021,27(01):137.